S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis

J Neurochem. 2013 Jan;124(1):45-58. doi: 10.1111/jnc.12046. Epub 2012 Nov 1.

Abstract

A major hallmark of mutant superoxide dismutase (SOD1)-linked familial amyotrophic lateral sclerosis is SOD1-immunopositive inclusions found within motor neurons. The mechanism by which SOD1 becomes aggregated, however, remains unclear. In this study, we aimed to investigate the role of nitrosative stress and S-nitrosylation of protein disulfide isomerase (PDI) in the formation of SOD1 aggregates. Our data show that with disease progression inducible nitric oxide synthase (iNOS) was up-regulated, which generated high levels of nitric oxide (NO) and subsequently induced S-nitrosylation of PDI in the spinal cord of mutant SOD1 transgenic mice. This was further confirmed by in vitro observation that treating SH-SY5Y cells with NO donor S-nitrosocysteine triggered a dose-dependent formation of S-nitrosylated PDI. When mutant SOD1 was over-expressed in SH-SY5Y cells, the iNOS expression was up-regulated, and NO generation was consequently increased. Furthermore, both S-nitrosylation of PDI and the formation of mutant SOD1 aggregates were detected in the cells expressing mutant SOD1(G93A). Blocking NO generation with the NOS inhibitor N-nitro-L-arginine attenuated the S-nitrosylation of PDI and inhibited the formation of mutant SOD1 aggregates. We conclude that NO-mediated S-nitrosylation of PDI is a contributing factor to the accumulation of mutant SOD1 aggregates in amyotrophic lateral sclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / genetics*
  • Amyotrophic Lateral Sclerosis / pathology
  • Animals
  • Arginine / pharmacology
  • Biotin / metabolism
  • Cell Line, Tumor
  • Cysteine / analogs & derivatives
  • Disease Models, Animal
  • Disease Progression
  • Humans
  • Male
  • Mice
  • Mice, Transgenic
  • Mutation / genetics*
  • Neuroblastoma / pathology
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Protein Disulfide-Isomerases / metabolism*
  • Protein Folding / drug effects
  • S-Nitrosothiols
  • Spinal Cord / metabolism
  • Spinal Cord / pathology
  • Subcellular Fractions / drug effects
  • Subcellular Fractions / metabolism
  • Superoxide Dismutase / genetics*
  • Up-Regulation / drug effects
  • Up-Regulation / genetics*

Substances

  • S-Nitrosothiols
  • Nitric Oxide
  • Biotin
  • S-nitrosocysteine
  • Arginine
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • SOD1 G93A protein
  • Superoxide Dismutase
  • Protein Disulfide-Isomerases
  • Cysteine